MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2021

    Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area

    R. Patel, G. Stebbins, B. Barton (Chicago, USA)

    Objective: To assess morbidity and mortality of acute COVID-19 infection in hospitalized patients with neurodegenerative diseases and compare with age-matched controls. Background: Outcomes from COVID-19…
  • MDS Virtual Congress 2021

    Effect of physical exercises on gait speed in patients with Parkinson’s disease

    D. Bueno, L. Oliveira, L. Ota, P. Polidoro, G. da Costa (Dracena, Brazil)

    Objective: To verify the effect of the application of physical exercises with a dual task on gait speed and the occurrence of falls in people…
  • MDS Virtual Congress 2021

    Early versus later levodopa and onset of motor fluctuations in PD: Observations from the Parkinson’s Outcomes Project

    S. Chiu, A. Ramirez-Zamora, B. Patel, S. Wu, H. Gao, O. Nguyen, I. Malaty (Gainesville, USA)

    Objective: To characterize patients with early versus later levodopa exposure, defining “early” as within 2 years of Parkinson’s disease (PD) diagnosis, and to determine whether…
  • MDS Virtual Congress 2021

    Predictors of survival in Progressive Supranuclear Palsy in a Tunisian cohort

    A. Neji, A. Nasri, I. Sghaier, S. Mrabet, M. Bendjebara, I. Kacem, R. Gouider (Tunis, Tunisia)

    Objective: To investigate survival and its determinants in a Tunisian cohort of Progressive Supranuclear Palsy (PSP). Background: PSP is a neurodegenerative tauopathy characterized by faster…
  • MDS Virtual Congress 2021

    How Covid-19 would affect parkinsonism patients’ mortality

    M. Salari, M. Etemadifar, S. Tehrani Fateh, Z. Aminzade (Tehran, Islamic Republic of Iran)

    Objective: To investigate the prevalence and mortality of Covid-19 among parkinsonism patients in addition to worsening of motor symptoms of these patients. Background: Parkinsonism can…
  • MDS Virtual Congress 2021

    Determination of 5-HT3 receptor levels with [3H]-GR 65630 binding in hemi-parkinsonian rats with L-DOPA induced dyskinesia

    C. Kwan, D. Bédard, I. Frouni, A. Hamadjida, P. Huot (Montreal, Canada)

    Objective: To determine the distribution of serotonin type 3 (5-HT3) receptors in brain areas implicated in L-3,4-dihydroxyphenylalanine (L-DOPA) induced dyskinesia in the 6-hydroxydopamine (6-OHDA)-lesioned rat…
  • MDS Virtual Congress 2021

    The prevalence of sarcopenia in Parkinson’s disease and related disorders

    A. Hart, F. Barker, A. Sayer, A. Granic, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To systematically review the prevalence of sarcopenia in Parkinson’s disease (PD) and atypical parkinsonian syndromes (aPS), how prevalence differs with PD stage and between…
  • MDS Virtual Congress 2021

    The Use Of Bioness L300 Go Results In Functional Gait Improvement In Patients With Parkinson’s Plus Syndromes.

    R. Lovell (Altadena, USA)

    Objective: To describe the efficacy of use of Bioness L300 Go FES System to result in functional improvement in gait related impairments in persons with…
  • MDS Virtual Congress 2020

    Creating National Competencies in Physical Activity for Exercise Professionals Working with People with Parkinson’s Disease

    L. Hoffman, M. Rafferty (New York, NY, USA)

    Objective: On March 5-6th 2020, the Parkinson’s Foundation is convening a meeting to assemble thought leaders in physical activity and education for Parkinson’s disease.  Our…
  • MDS Virtual Congress 2020

    Movement disorders and it association with immunological causes: the key is in the movement

    E.M Gatto, G. Da Prat, J.L Etcheverry, M.E Cesarini, N. Gonzalez Rojas (CABA, Argentina)

    Objective: Observe the clinical and biochemical characteristics and the result of the treatment instituted in movement immune-mediated etiology. Background: Paraneoplastic autoimmune movement disorders are a…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley